Literature DB >> 11504404

Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence.

H H Garcia1, A E Gonzalez, R H Gilman, L G Palacios, I Jimenez, S Rodriguez, M Verastegui, P Wilkins, V C Tsang.   

Abstract

The discordance between extremely high seroprevalence of Taenia solium antibodies in disease-endemic populations, relatively few symptomatic cases of neurocysticercosis, and high background levels of putatively inactive brain lesions (mainly calcifications) in seronegative controls have confused researchers, clinicians, and epidemiologists in the last decade. We reviewed longitudinal serologic data from general population serosurveys in 3 different disease-endemic areas of Peru and Colombia and found that approximately 40% of seropositive people were seronegative when resampled after 1 year (3 surveys) or after 3 years (1 survey). Transient antibodies may have significant implications for the epidemiology of and immunity to this disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504404     DOI: 10.4269/ajtmh.2001.65.31

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  47 in total

1.  Infection with versus exposure to Taenia solium: what do serological test results tell us?

Authors:  Nicolas Praet; Richar Rodriguez-Hidalgo; Niko Speybroeck; Serge Ahounou; Washington Benitez-Ortiz; Dirk Berkvens; Anke Van Hul; Margoth Barrionuevo-Samaniego; Claude Saegerman; Pierre Dorny
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 2.  Under seize: neurocysticercosis in an immigrant woman and review of a growing neglected disease.

Authors:  Meredith Bock; Hector H Garcia; Peter Chin-Hong; Sanjiv M Baxi
Journal:  BMJ Case Rep       Date:  2015-12-18

Review 3.  Laboratory Diagnosis of Neurocysticercosis (Taenia solium).

Authors:  Hector H Garcia; Seth E O'Neal; John Noh; Sukwan Handali
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

4.  Cysticercosis and epilepsy in rural Tanzania: a community-based case-control and imaging study.

Authors:  Ewan Hunter; Kathryn Burton; Ahmed Iqbal; Daniel Birchall; Margaret Jackson; Jane Rogathe; Ahmed Jusabani; William Gray; Eric Aris; Gathoni Kamuyu; Patricia P Wilkins; Charles R Newton; Richard Walker
Journal:  Trop Med Int Health       Date:  2015-05-26       Impact factor: 2.622

Review 5.  Neurocysticercosis: current knowledge and advances.

Authors:  Wayne X Shandera; Joseph S Kass
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

6.  Multiantigen print immunoassay for comparison of diagnostic antigens for Taenia solium cysticercosis and taeniasis.

Authors:  Sukwan Handali; Molly Klarman; Amanda N Gaspard; John Noh; Yeuk-Mui Lee; Silvia Rodriguez; Armando E Gonzalez; Hector H Garcia; Robert H Gilman; Victor C W Tsang; Patricia P Wilkins
Journal:  Clin Vaccine Immunol       Date:  2009-11-11

Review 7.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

8.  Seroprevalence of cysticercosis in children and young adults living in a helminth endemic community in leyte, the Philippines.

Authors:  Jin-Mei Xu; Luz P Acosta; Min Hou; Daria L Manalo; Mario Jiz; Blanca Jarilla; Archie O Pablo; Remigio M Ovleda; Gretchen Langdon; Stephen T McGarvey; Jonathan D Kurtis; Jennifer F Friedman; Hai-Wei Wu
Journal:  J Trop Med       Date:  2010-03-29

Review 9.  Immunology of Taenia solium taeniasis and human cysticercosis.

Authors:  H H Garcia; S Rodriguez; J S Friedland
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

10.  The disease burden of Taenia solium cysticercosis in Cameroon.

Authors:  Nicolas Praet; Niko Speybroeck; Rafael Manzanedo; Dirk Berkvens; Denis Nsame Nforninwe; André Zoli; Fabrice Quet; Pierre-Marie Preux; Hélène Carabin; Stanny Geerts
Journal:  PLoS Negl Trop Dis       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.